© 2022 All rights reserved.
AI Medical Technology AI Medical Technology
  • Home
  • Dermalyser
  • About
  • Research
  • News
Contact Us
AI Medical Technology
Contact Us

Driving Fast, Accurate Diagnosis for All Skin Cancers

Dermalyser

Dermalyser is a diagnostic decision support system (DDSS) empowered with advanced artificial intelligence (AI). The primary function is to classify skin cancer such as malignant melanoma using image analysis combined with deep learning (AI). The artificial intelligence is developed and trained based on quality-controlled dermatoscopic images of patients’ skin lesions together with associated patient data. Medical professionals,  for example general practitioners, use the solution/application on a mobile phone together with a dermatoscope mounted in front of the mobile phone camera. The general practitioner takes a picture of the patient’s skin lesion and receives a melanoma risk label within a few seconds with higher diagnostic precision and speed than traditional and alternative methods.

Watch Video

Watch our short demonstration video to see how Dermalyser works.

How Dermalyser Works

Dermalyser is extremely practical and easy to use, and can be integrated into routine clinical practice in four simple steps.

Dermalyser – Start – Start screen
1 Download the App

Easily download the Dermalyser app on to any mobile device. The app works on both Android or iOS.

Dermalyser – Patient Info – Terms and Agreement Consent 1
2 Enter In Patient's Details

Securely upload the patient’s details to the app, including age and sex
.

Dermalyser – Camera – Start 2
3 Take a Picture

Using a dermascope, which can be easily attached to the device camera, take a picture of the suspect skin lesion

Dermalyser – Results – Melanoma Detected – Melanoma Only 2.2
4 Receive Results

The image is analysed using our proprietary AI software and reports back the malignancy risk in real time

Performance (AUC) of Dermalyser

In a test with more than 6000 unseen images, our AI achieved an AUC score of 0.94 which significantly outperforms Expert Dermatologists and General Practitioners.

AI Medical Graphic chart

Advantages of Using Dermalyser

Dermalyser offers multiple benefits over traditional diagnostic pathways for skin cancer and other available solutions.

Fewer Melanomas Missed And Increased Performance

We have a carefully curated database comprising over 100,000 images of fully labelled skin lesions that have been used to train our proprietary AI, enabling industry leading sensitivity and better performance.

Dermalyser – Results – Melanoma Detected – Melanoma Only 2.2

Reduced Number of Unnecessary Skin Excisions

Supports reduction of unnecessary skin excisions thereby improving healthcare economics across multiple levels.

Dermalyser – Results – Melanoma Not Detected – Melanoma Only 2.2

Easy And Convenient

AI empowered image analysis software enables easy analysis of a patient’s skin lesion on any mobile phone.

Dermalyser – Start – Intro 2
AI Medical Technology logo colour

Website Privacy Policy

Contact Us

Dermalyser

BSI

+46 721748339
Stockholm, Sweden

© 2022 All rights reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.AcceptPrivacy policy